Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.

Otten HG, Calis JJ, Keşmir C, van Zuilen AD, Spierings E.

Hum Immunol. 2013 Mar;74(3):290-6. doi: 10.1016/j.humimm.2012.12.004. Epub 2012 Dec 8.

PMID:
23232063
2.

Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.

Duquesnoy RJ, Awadalla Y, Lomago J, Jelinek L, Howe J, Zern D, Hunter B, Martell J, Girnita A, Zeevi A.

Transpl Immunol. 2008 Feb;18(4):352-60. Epub 2007 Oct 30.

3.

Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.

Wiebe C, Pochinco D, Blydt-Hansen TD, Ho J, Birk PE, Karpinski M, Goldberg A, Storsley LJ, Gibson IW, Rush DN, Nickerson PW.

Am J Transplant. 2013 Dec;13(12):3114-22. doi: 10.1111/ajt.12478. Epub 2013 Oct 25.

4.

Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.

Proust B, Kennel A, Ladrière M, Kessler M, Perrier P.

Transpl Immunol. 2009 Jul;21(3):166-8. doi: 10.1016/j.trim.2009.03.003. Epub 2009 Mar 31.

PMID:
19341797
5.

Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.

Worthington JE, Martin S, Al-Husseini DM, Dyer PA, Johnson RW.

Transplantation. 2003 Apr 15;75(7):1034-40.

PMID:
12698094
6.

Predicted Indirectly Recognizable HLA Epitopes Presented by HLA-DRB1 Are Related to HLA Antibody Formation During Pregnancy.

Geneugelijk K, Hönger G, van Deutekom HW, Thus KA, Keşmir C, Hösli I, Schaub S, Spierings E.

Am J Transplant. 2015 Dec;15(12):3112-22. doi: 10.1111/ajt.13508. Epub 2015 Oct 29.

PMID:
26512793
7.
8.

Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients.

Ravindranath MH, Pham T, Ozawa M, Terasaki PI.

Int Immunol. 2012 Jan;24(1):43-57. doi: 10.1093/intimm/dxr094. Epub 2011 Dec 20.

9.

Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.

Resse M, Paolillo R, Casamassimi A, Cavalca F, Fiorito C, Maiello C, Napoli C.

Hum Immunol. 2013 Aug;74(8):937-41. doi: 10.1016/j.humimm.2013.04.033. Epub 2013 Apr 27.

PMID:
23628396
10.

Kidney graft failure and presensitization against HLA class I and class II antigens.

Süsal C, Opelz G.

Transplantation. 2002 Apr 27;73(8):1269-73.

PMID:
11981420
11.

Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker.

Kosmoliaptsis V, Bradley JA, Sharples LD, Chaudhry A, Key T, Goodman RS, Taylor CJ.

Transplantation. 2008 Jun 27;85(12):1817-25. doi: 10.1097/TP.0b013e31817441d6.

PMID:
18580476
12.

Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens.

van Kampen CA, Versteeg-van der Voort Maarschalk MF, Roelen DL, ten Berge IJ, Claas FH.

Transplantation. 2001 Apr 15;71(7):869-74.

PMID:
11349718
14.

Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.

Piazza A, Poggi E, Ozzella G, Borrelli L, Monaco PI, Scornajenghi A, Tisone G, Adorno D.

Transplantation. 2006 May 15;81(9):1298-305.

PMID:
16699458
15.

Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes.

Thus KA, Ruizendaal MT, de Hoop TA, Borst E, van Deutekom HW, Te Boome L, Kuball J, Spierings E.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1705-10. doi: 10.1016/j.bbmt.2014.06.026. Epub 2014 Jun 26.

16.

Characterization of antiidiotypic antibodies to donor HLA that develop after liver transplantation.

Chauhan B, Phelan DL, Marsh JW, Mohanakumar T.

Transplantation. 1993 Aug;56(2):443-8.

PMID:
7689260
17.

Is there MHC Class II restriction of the response to MHC Class I in transplant patients?

Papassavas AC, Barnardo MC, Bunce M, Welsh KI.

Transplantation. 2002 Feb 27;73(4):642-51.

PMID:
11889447
18.
19.

Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance.

Smith JD, Hornick PI, Rasmi N, Rose ML, Yacoub MH.

Ann Thorac Surg. 1998 Dec;66(6 Suppl):S212-5.

PMID:
9930450
20.

Effect of amino acid mismatch in the UNOS dataset.

Sasaki N, El-Awar N, Idica A.

Clin Transpl. 2011:299-309.

PMID:
22755423
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk